Equity research: novo nordisk
The aim of the thesis is that to asses show the future will unfold for the pharma company Novo Nordisk taking into account the entry of a disruptive and innovative competitor: Virta Health. As we will later further develop, Novo Nordisk has a strong pipeline of products, with its main focus on Diabe...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/133498 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/133498 |